Market Overview

Benzinga's Top Pre-Market Losers

Related JCP
Social Media Beat: What Experts And The Crowd Think Of Macy's, J C Penney And Target Into The Holiday Season
J.C. Penney Has 61% Upside? Buckingham Research Thinks So
Black Friday: Midnight Madness At The Mall - Abercrombie, Hollister, American Eagle And Aeropostale Rock (Seeking Alpha)
Related NKTR
Endologix, Express, Rockwell Automation Lead After-Hours Movers To Close Holiday Week
Baxalta Announces FDA Approval of ADYNOVATE Treatment for Hemophilia A

Nektar Therapeutics (NASDAQ: NKTR) dipped 24.19% to $10.50 in the pre-market session after the company reported that the results from Phase 2 trial of NKTR-181 missed primary efficacy endpoint.

Zoltek Companies (NASDAQ: ZOLT) shares dropped 10.05% to $16.65 in pre-market trading after Toray Industries agreed to buy Zoltek Companies for $16.75 per share.

J. C. Penney Company (NYSE: JCP) shares fell 8.54% to $9.53 in the pre-market trading after the company priced its underwritten public offering of 84.0 million shares of its common stock at $9.65 per share.

Accenture (NYSE: ACN) dipped 4.18% to $72.70 in the pre-market session after the company reported a rise in its fiscal fourth-quarter net income. For the current fiscal year, the company projected net income of $4.42 to $4.54 per share, versus analysts' expectations of $4.50 per share.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (ACN + JCP)

Get Benzinga's Newsletters